{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T06:38:56Z","timestamp":1789799936081,"version":"4.0.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2283,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,6]]},"abstract":"<jats:title>\n                           <jats:bold>Abstract<\/jats:bold>\n                        <\/jats:title>\n          <jats:sec>\n            <jats:title\/>\n            <jats:p>We studied histological features and long-term outcomes in patients with progressive familial intrahepatic cholestasis type 1 (PFIC1) after liver transplantation (LT). Histological findings were correlated with the post-LT course and treatment in 11 recipients with PFIC1. Ages at LT varied from 1 to 18 years (median, 4 years). Macrovesicular steatosis was observed in 8 patients at a median of 60 days post-LT (range, 21-191 days). Severe steatosis progressed to steatohepatitis in 7 patients at a median of 161 days (range, 116-932 days). The patients were followed up for a median of 7.3 years (range, 2.3-16.1 years). Six showed bridging fibrosis, with 2 progressing to cirrhosis. One patient with cirrhosis died because of the rupture of a splenic artery aneurysm 13.6 years post-LT. Post-LT refractory diarrhea was present in all 8 having steatosis. Three without post-LT diarrhea showed no allograft steatosis. Bile adsorptive resin therapy reduced the diarrhea and steatosis. Patients with posttransplant steatosis typically had more severe mutations of the ATPase class I type 8B member 1 (<jats:italic toggle=\"yes\">ATP8B1<\/jats:italic>) gene and were more likely to have systemic complications such as pancreatitis. In conclusion, allograft steatosis was present in patients with PFIC1, progressing to steatohepatitis and cirrhosis. Because expression of the familial intrahepatic cholestasis 1 gene occurs in several organs, including the small intestine, pancreas, and liver, and it is involved in enterohepatic bile acid circulation, post-LT steatosis may be due to a malfunction of the <jats:italic toggle=\"yes\">ATP8B1<\/jats:italic> product. Liver Transpl 15:610\u2013618, 2009. \u00a9 2009 AASLD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/lt.21686","type":"journal-article","created":{"date-parts":[[2009,5,28]],"date-time":"2009-05-28T20:04:09Z","timestamp":1243541049000},"page":"610-618","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":90,"title":["Allograft Steatohepatitis in Progressive Familial Intrahepatic Cholestasis Type 1 After Living Donor Liver Transplantation"],"prefix":"10.1097","volume":"15","author":[{"given":"Aya","family":"Miyagawa-Hayashino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Egawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Yorifuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Haga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuaki","family":"Tsuruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Chin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Sumazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Manabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Uemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20250330","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1001\/archpedi.1969.02100030114014","article-title":"Byler disease. Fatal familial intrahepatic cholestasis in an Amish kindred.","volume":"117","author":"Clayton","year":"1969","journal-title":"Am J Dis Child"},{"key":"R2-8-20250330","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/ng0398-219","article-title":"A gene encoding a Ptype ATPase mutated in two forms of hereditary cholestasis.","volume":"18","author":"Bull","year":"1998","journal-title":"Nat Genet"},{"key":"R3-8-20250330","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/hmg\/4.6.1049","article-title":"Mapping of a locus for progressive familial intrahepatic cholestasis (Byler disease) to 18q21-q22, the benign recurrent intrahepatic cholestasis region.","volume":"4","author":"Carlton","year":"1995","journal-title":"Hum Mol Genet"},{"key":"R4-8-20250330","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0168-8278(01)00158-1","article-title":"FIC1, the protein affected in two forms of hereditary cholestasis, is localized in the cholangiocyte and the canalicular membrane of the hepatocyte.","volume":"35","author":"Eppens","year":"2001","journal-title":"J Hepatol"},{"key":"R5-8-20250330","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1053\/jhep.2001.27663","article-title":"Familial intrahepatic cholestasis 1: studies of localization and function.","volume":"34","author":"Ujhazy","year":"2001","journal-title":"Hepatology"},{"key":"R6-8-20250330","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1203\/01.PDR.0000145564.06791.D1","article-title":"Fic1 is expressed at apical membranes of different epithelial cells in the digestive tract and is induced in the small intestine during postnatal development of mice.","volume":"56","author":"van Mil","year":"2004","journal-title":"Pediatr Res"},{"key":"R7-8-20250330","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0016-5085(88)90301-0","article-title":"Partial external diversion of bile for the treatment of intractable pruritus associated with intrahepatic cholestasis.","volume":"95","author":"Whitington","year":"1988","journal-title":"Gastroenterology"},{"key":"R8-8-20250330","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/0022-3468(95)90440-9","article-title":"Selective surgical management of progressive familial intrahepatic cholestasis (Bylers disease).","volume":"30","author":"Emond","year":"1995","journal-title":"J Pediatr Surg"},{"key":"R9-8-20250330","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1034\/j.1399-3046.1999.00046.x","article-title":"Treatment of progressive familial intrahepatic cholestasis: liver transplantation or partial external biliary diversion.","volume":"3","author":"Ismail","year":"1999","journal-title":"Pediatr Transplant"},{"key":"R10-8-20250330","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1111\/j.1572-0241.2000.03370.x","article-title":"Progressive familial intrahepatic cholestasis: partial biliary diversion normalizes serum lipids and improves growth in noncirrhotic patients.","volume":"95","author":"Melter","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"R11-8-20250330","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1055\/s-2003-43570","article-title":"Surgical treatment of progressive familial intrahepatic cholestasis: comparison of partial external biliary diversion and ileal bypass.","volume":"13","author":"Kalicinski","year":"2003","journal-title":"Eur J Pediatr Surg"},{"key":"R12-8-20250330","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1016\/j.transproceed.2003.10.047","article-title":"Living related liver transplantation in 13 cases of progressive familial intrahepatic cholestasis.","volume":"35","author":"Bassas","year":"2003","journal-title":"Transplant Proc"},{"key":"R13-8-20250330","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.transproceed.2005.01.041","article-title":"Orthotopic liver transplantation for Bylers disease.","volume":"37","author":"Torri","year":"2005","journal-title":"Transplant Proc"},{"key":"R14-8-20250330","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0168-8278(03)00286-1","article-title":"Progressive familial intrahepatic cholestasis type 1 and extrahepatic features: no catchup of stature growth, exacerbation of diarrhea, and appearance of liver steatosis after liver transplantation.","volume":"39","author":"Lykavieris","year":"2003","journal-title":"J Hepatol"},{"key":"R15-8-20250330","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1399-3046.2006.00524.x","article-title":"Safety of livingrelated liver transplantation for progressive familial intrahepatic cholestasis.","volume":"10","author":"Cutillo","year":"2006","journal-title":"Pediatr Transplant"},{"key":"R16-8-20250330","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.TP.0000132328.33460.43","article-title":"Outcome and risk factors of de novo autoimmune hepatitis in livingdonor liver transplantation.","volume":"78","author":"MiyagawaHayashino","year":"2004","journal-title":"Transplantation"},{"key":"R17-8-20250330","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/hep.510250328","article-title":"Banff schema for grading liver allograft rejection: an international consensus document.","volume":"25","year":"1997","journal-title":"Hepatology"},{"key":"R18-8-20250330","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hep.510310337","article-title":"Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An international panel.","volume":"31","author":"Demetris","year":"2000","journal-title":"Hepatology"},{"key":"R19-8-20250330","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2001-12925","article-title":"Nonalcoholic steatohepatitis: definition and pathology.","volume":"21","author":"Brunt","year":"2001","journal-title":"Semin Liver Dis"},{"key":"R21-8-20250330","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1053\/jlts.2002.34384","article-title":"Intractable diarrhea after liver transplantation for Bylers disease: successful treatment with bile adsorptive resin.","volume":"8","author":"Egawa","year":"2002","journal-title":"Liver Transpl"},{"key":"R22-8-20250330","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0140-6736(97)06478-7","article-title":"Denovo autoimmune hepatitis after liver transplantation.","volume":"351","author":"Kerkar","year":"1998","journal-title":"Lancet"},{"key":"R23-8-20250330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0304-4157(95)00017-8","article-title":"Structural organization, ion transport, and energy transduction of Ptype ATPases.","volume":"1286","author":"Mller","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"R24-8-20250330","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1002\/hep.1840220616","article-title":"The natural history of nonalcoholic fatty liver: a followup study.","volume":"22","author":"Teli","year":"1995","journal-title":"Hepatology"},{"key":"R25-8-20250330","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/hep.1840110114","article-title":"The natural history of nonalcoholic steatohepatitis: a followup study of fortytwo patients for up to 21 years.","volume":"11","author":"Powell","year":"1990","journal-title":"Hepatology"},{"key":"R26-8-20250330","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0016-5085(94)90235-6","article-title":"Nonalcoholic steatohepatitis: an expanded clinical entity.","volume":"107","author":"Bacon","year":"1994","journal-title":"Gastroenterology"},{"key":"R27-8-20250330","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology"},{"key":"R28-8-20250330","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1053\/jhep.2003.50193","article-title":"Nonalcoholic steatohepatitis: summary of an AASLD single topic conference.","volume":"37","author":"NeuschwanderTetri","year":"2003","journal-title":"Hepatology"},{"key":"R29-8-20250330","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0016-5085(98)70590-6","article-title":"Steatohepatitisinducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes.","volume":"114","author":"Berson","year":"1998","journal-title":"Gastroenterology"},{"key":"R30-8-20250330","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1440-1827.1999.00829.x","article-title":"Reactive oxygen speciesinduced molecular damage and its application in pathology.","volume":"49","author":"Toyokuni","year":"1999","journal-title":"Pathol Int"},{"key":"R31-8-20250330","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.hepres.2005.09.020","article-title":"Clinicopathological significance of oxidative cellular damage in nonalcoholic fatty liver diseases.","volume":"33","author":"Seki","year":"2005","journal-title":"Hepatol Res"},{"key":"R32-8-20250330","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1399-3046.2007.00722.x","article-title":"Liver transplantation for progressive familial intrahepatic cholestasis: clinical and histopathological findings, outcome and impact on growth.","volume":"11","author":"Aydogdu","year":"2007","journal-title":"Pediatr Transplant"},{"key":"R33-8-20250330","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/S0016-5085(99)70287-8","article-title":"Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis.","volume":"117","author":"Jansen","year":"1999","journal-title":"Gastroenterology"},{"key":"R34-8-20250330","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1053\/j.gastro.2003.12.013","article-title":"Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity.","volume":"126","author":"Chen","year":"2004","journal-title":"Gastroenterology"},{"key":"R35-8-20250330","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jhep.2007.02.011","article-title":"Intestinal bile salt absorption in Atp8b1 deficient mice.","volume":"47","author":"Groen","year":"2007","journal-title":"J Hepatol"},{"key":"R36-8-20250330","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0140-6736(05)77221-4","article-title":"Heterozygous nonsense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy.","volume":"353","author":"Jacquemin","year":"1999","journal-title":"Lancet"},{"key":"R37-8-20250330","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/hep.20997","article-title":"Parenteral nutritionassociated liver disease and the role for isolated intestine and intestineliver transplantation.","volume":"43","author":"Buchman","year":"2006","journal-title":"Hepatology"},{"key":"R38-8-20250330","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2174\/1568008054064878","article-title":"Manipulation of biliary lipids by gene therapy: potential consequences for patients with progressive familial intrahepatic cholestasis.","volume":"5","author":"Oude Elferink","year":"2005","journal-title":"Curr Drug Targets Immune Endocr Metab Disord"}],"container-title":["Liver Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.21686","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01445473-200906000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T23:49:42Z","timestamp":1743378582000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01445473-200906000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.21686","relation":{},"ISSN":["1527-6465"],"issn-type":[{"value":"1527-6465","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}